BRCA1 and neoplasm: Cisplatin is an alkylating agent; it can negatively regulate cell cycle progression in certain types of tumor cells.17, 18 In Figure 4C, BRCA1 knockout resulted in a significant G2/M phase arrest in EOCSCs, indicating that the sensitivity of sh‐BRCA1 EOCSCs to cisplatin was significantly increased.